Season’s greetings and best wishes to our Colleagues, Members and Partners

At this special time of the year, we want to take the opportunity to thank you for your continued collaboration and support throughout 2020. Your commitment, ideas and projects keep us loving what we do each day.

The DNA regions in our brain that contribute to make us human

With only 1% difference, the human and chimpanzee protein-coding genomes are remarkably similar. Understanding the biological features that make us human is part of a fascinating debated line of research.

Machine Learning in Swiss bioinformatics: applications and challenges

How is machine learning and deep learning used across bioinformatics? Do all ML models necessarily need to be explainable? How can trust from end-users of ML powered applications be fostered?

Collaborating with Cellestia Biotech to launch new drug discovery program

Cellestia Biotech is initiating a new drug discovery program focused on TFs. The programme, which addresses unmet medical needs in cancer, autoimmune and inflammatory disorders (AIIDs), is launched in collaboration with Vincent Zoete

A key ingredient of Swiss precision oncology: SVIP-O goes live

The Swiss Variant Interpretation Platform for Oncology (SVIP-O) was launched by SIB, ETH Zurich and HES-SO to offer a harmonized interpretation of cancer variants to clinicians. SVIP-O, now available in its first public version,

Discover the world of biomedicine with the new

A new version of ChromosomeWalk offers a gateway to an entertaining ‘genome browser’, enriched with a new selection of stories on fascinating genes – in English, French and German – as well to the PrecisionMed website for an illustrated tour of precision medicine.

In memoriam: Guy-Olivier Segond, first President of SIB’s Foundation Council

On 12 November 2020, Geneva State Councillor Guy-Olivier Segond passed away at the age of 75. It is thanks to his visionary nature that SIB was established in 1998.

The SPHN fact-sheet 2020 is out

Find out about the current status of the Swiss Personalized Health Network (SPHN) – a project of the Swiss Academy of Medical Sciences (SAMS) and SIB -, its perspectives and goals for the next funding period.